Merck Healthcare signs MoU with Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC)

New Delhi, India – March 21, 2024 – Merck India, a leading science and technology company committed to supporting cancer patients, today announced a strategic partnership with the renowned Rajiv Gandhi Cancer Institute and Research Centre under the Umeed program. This collaborative initiative aims to bolster access to cancer care for patients affected by head & neck, and colorectal cancer.

Read more